Zdrowie i gospodarka · 30.03.2007
Draft Guidance for Industry and Review Staff on Target Product Profile-A Strategic Development Process Tool; Availability
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry and review staff entitled "Target Product Profile--A Strategic Development Process Tool." The purpose of this guidance is to inform sponsors and the review staff in the Center for Drug Evaluation and Research (CDER) of the availability and potential usefulness of a target product profile (TPP). A TPP can be prepared by a sponsor and then shared voluntarily with the appropriate FDA review staff to facilitate communication regarding a particular drug development program. This draft guidance describes the purposes of a TPP, provides guidance on how to complete a TPP, makes suggestions on how to best use a TPP, and relates case studies that demonstrate the potential usefulness of a TPP.